A combination of vitamin E (1000 IU/day) and pentoxifylline (800 mg/day) completely reversed a case of radiation-induced cervicothoracic fibrosis in a 67-year-old woman after an 18-month course of treatment
Diaphyseal Shortening method (using internal fixation plate/screws) higher complication rate (delayed union, nonunion, hardware removal)
About 4% of GLP-1 users developed osteoporosis, compared with a little over 3% of nonusers an increased risk of about 30%
Orforglipron (brand name: Foundayo), a once-daily pill-based weight-loss drug that targets the same GLP-1 system as Wegovy, has recently been approved by the US Food and Drug Administration for treating obesity
Second, information on outcomes, comorbidities and cardiovascular risk factors was derived from administrative claims, which may be less reliable than trial-based assessments
A recent large-scale clinical trial has confirmed that tirzepatide, a dual GIP and GLP-1RAs, resulted in a weight loss of up to 20.9% in adults with body fat mass of 30 or more after 72-week follow-up [22]
